The global healthcare community across the United States, United Kingdom, Germany, Japan, China, Canada, France, Netherlands, Switzerland, Australia, Dubai, Finland, and Austria continuously evaluates the complex boundaries between potent central nervous system stimulants, prescription medications, and emerging consciousness-altering substances. As public health networks explore innovative treatments for psychiatric disorders, academic investigators frequently encounter widespread public […]